UNSPSC 51293600: Antidepressant indoles

Antidepressant drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.

UNSPSC 51293600 Antidepressant indoles is a Class code, but recent state and local solicitations under this code do not target antidepressant drugs at all. Instead, activity centers on naloxone (an opioid antagonist used in overdose response), generic multi-source pharmaceuticals for broad distribution, and pharmaceutical supply chain management through direct-to-manufacturer models. State and local governments use this code to procure pharmaceutical products and systems that support community health, emergency response, and pharmacy benefit management across health departments, cooperative purchasing alliances, and state agencies. Issuing bodies include county health authorities (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance, which serves multiple states including Oregon).

Recent opportunities span Florida, Texas, and Minnesota. Seminole County issued IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building, with bids due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to improve prescription fulfillment and cost management outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with proposals due March 26, 2026, and contract awards effective July 1, 2026. The mismatch between the code's nominal scope (antidepressant indoles) and the actual solicitations suggests this code receives minimal relevant pharmaceutical-category activity; the recent postings indicate state and local procurement offices are using it as a catch-all for pharmaceutical procurement broadly.